Alliance of epigenetic forces for the activation of oncogenic Wnt/β-catenin signaling

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 3, 2013, Pages 383-385

  Bai, Alfa Hc ^a   Cheng, Alfred Sl ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CATENIN; MICRORNA; TRANSCRIPTION FACTOR SOX1; WNT PROTEIN;

CANCER CELL; CANCER GROWTH; CANCER RESEARCH; CELL CYCLE PROGRESSION; CELL PROLIFERATION; DNA METHYLATION; EDITORIAL; EMBRYO DEVELOPMENT; EPIGENETICS; GENE MUTATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER REGENERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; WNT SIGNALING PATHWAY;

EID: 84874366186     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12090     Document Type: Editorial

References (20)

1. Polakis P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 2012; 4: doi: 10.1101/cshperspect.a008052.
2. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell 2012; 149: 1192-1205.
3. Nejak-Bowen KN, Thompson MD, Singh S etal. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. Hepatology 2010; 51: 1603-1613.
4. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer 2011; 11: 726-734.
5. Wong CM, Fan ST, Ng IO. Beta-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 2001; 92: 136-145.
6. Cheng ASL, Lau SS, Chen Y etal. EZH2-mediated concordant repression of Wnt antagonists promotes -catenin-dependent hepatocarcinogenesis. Cancer Res. 2011; 71: 4028-4039.
7. Satoh S, Daigo Y, Furukawa Y etal. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 2000; 24: 245-250.
8. Taniguchi K, Roberts LR, Aderca IN etal. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 2002; 21: 4863-4871.
9. Shih Y-L, Hsieh C-B, Yan M-D etal. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2013; 28: 551-559.
10. Shih Y-L, Hsieh C-B, Lai H-C etal. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Int. J. Cancer 2007; 121: 1028-1035.
11. Tsao C-M, Yan M-D, Shih Y-L etal. SOX1 functions as a tumor suppressor through antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatology 2012; 56: 2277-2287.
12. Tsang DP, Cheng AS. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J. Gastroenterol. Hepatol. 2010; 26: 19-27.
13. Yu Z, Cheng AS-L. Epigenetic deregulation of MicroRNAs: new opportunities to target oncogenic signaling pathways in hepatocellular carcinoma. Curr. Pharm. Des. 2012; [epub ahead of print].
14. Zhang Y, Wei W, Cheng N etal. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 2012; 56: 1631-1640.
15. Stefanska B, Huang J, Bhattacharyya B etal. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res. 2011; 71: 5891-5903.
16. Neumann O, Kesselmeier M, Geffers R etal. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors. Hepatology 2012; 56: 1817-1827.
17. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-1273.
18. Feng H, Cheng ASL, Tsang DP etal. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. J. Clin. Invest. 2011; 121: 3159-3175.
19. Awuah PK, Monga SP. Cell cycle-related kinase links androgen receptor and β-catenin signaling in hepatocellular carcinoma: why are men at a loss? Hepatology 2012; 55: 970-973.
20. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat. Med. 2011; 17: 330-339.